Two new studies are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems during the day and insomnia at night.
Using machine learning to analyze video recordings of individuals performing simple movements, researchers developed a method to automaticaly quanitfy motor systems in early-stage Parkinson's disease and other movement disorders.
A research team examined the effect of Ecklonia cava polyphenols on the prevention of Parkinson's disease. It was found that the oral intake of the seaweed antioxidants restores motor function and protects dopaminergic neurons in model mice, while cellular experiments revealed the biochemical interaction of their preventive effect.
New research suggests that two proteins, amyloid- and phosphorylated tau, the key proteins of Alzheimer's disease, are detected in blood once symptoms have started in Lewy's body diseases, such as Parkinson's. They also found that monitoring the neurofilament light chain protein can detect Lewy body diseases prior to symptom development. The findings suggest a means of identifying potential patients and a new target for intervention.